The Cambridge Awards 2024 for Research Impact and Engagement
03 February 2025Meet the winner of the Cambridge Awards 2024 for Research Impact and Engagement and learn more about their projects.
Meet the winner of the Cambridge Awards 2024 for Research Impact and Engagement and learn more about their projects.
Professor Sir Roy Calne, the pioneering transplant surgeon who carried out the first liver transplant in the UK during his time at Cambridge, has died aged 93.
Men with early, curable stages of prostate cancer are missing opportunities to have their cancer detected because national guidelines and media health campaigns focus on urinary symptoms despite a lack of scientific evidence, say experts at the University of Cambridge.
Scientists have used a technique to grow bile duct organoids – often referred to as ‘mini-organs’ – in the lab and shown that these can be used to repair damaged human livers. This is the first time that the technique has been used on human organs.
Cambridge scientists have developed a new method for growing and transplanting artificial bile ducts that could in future be used to help treat liver disease in children, reducing the need for liver transplantation.
There’s a nationwide shortage of suitable organs for transplanting – but what if some of those organs deemed ‘unsuitable’ could be rejuvenated? Researchers at Addenbrooke’s Hospital have managed just that – and last year gave two patients an unexpected Christmas present.
An experimental cystic fibrosis drug has been shown to prevent the disease’s damage to the liver, thanks to a world-first where scientists grew mini bile ducts in the lab.
The University of Cambridge has received £7.9 million from the National Institute for Health Research (NIHR) to fund Blood and Transplant Research Units. Each Unit is a partnership between University researchers and NHS Blood and Transplant, and will begin in October 2015.
Donor kidneys from individuals who have recently died from cardiac arrest perform just as well in recipients as kidneys from traditional 'brain-dead' donors, scientists have found.
The most common cause of artificial joint failure is loosening of the prosthetic implant. Dr Athina Markaki is designing materials to anchor them securely.